{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["39(5)"],"submitter":["Burnett AL"],"funding":["Astellas Pharma Global Development, Inc.","Astellas Pharma Global Development"],"pubmed_abstract":["<h4>Aims</h4>To characterize the epidemiology and treatment patterns of adult men (≥40 years) diagnosed with, or treated for, overactive bladder (OAB) and/or benign prostatic hyperplasia (BPH).<h4>Methods</h4>This retrospective observational study used data extracted from the IBM MarketScan Commercial Claims and Encounters database and the Medicare Supplemental Coordination of Benefits database. Men with BPH and/or OAB were identified and observed to assess treatment and diagnostic patterns.<h4>Results</h4>Within the entire study sample (N = 462 400), BPH diagnosis (61.5%) and BPH treatment (73.7%) were more common than the corresponding values for OAB (25.8% and 7.0%, respectively). Notably, among diagnosed individuals, the dispensation of a corresponding treatment was more likely in indi"],"journal":["Neurourology and urodynamics"],"pagination":["1378-1386"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7384148"],"repository":["biostudies-literature"],"pubmed_title":["Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study."],"pmcid":["PMC7384148"],"pubmed_authors":["Nimke D","Walker DR","Johnston KM","Hairston JC","Burnett AL","Feng Q","Lozano-Ortega G"],"additional_accession":[]},"is_claimable":false,"name":"Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study.","description":"<h4>Aims</h4>To characterize the epidemiology and treatment patterns of adult men (≥40 years) diagnosed with, or treated for, overactive bladder (OAB) and/or benign prostatic hyperplasia (BPH).<h4>Methods</h4>This retrospective observational study used data extracted from the IBM MarketScan Commercial Claims and Encounters database and the Medicare Supplemental Coordination of Benefits database. Men with BPH and/or OAB were identified and observed to assess treatment and diagnostic patterns.<h4>Results</h4>Within the entire study sample (N = 462 400), BPH diagnosis (61.5%) and BPH treatment (73.7%) were more common than the corresponding values for OAB (25.8% and 7.0%, respectively). Notably, among diagnosed individuals, the dispensation of a corresponding treatment was more likely in indi","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jun","modification":"2025-04-19T23:03:13.563Z","creation":"2025-04-19T23:03:13.563Z"},"accession":"S-EPMC7384148","cross_references":{"pubmed":["32383533"],"doi":["10.1002/nau.24348"]}}